Professor of Neurology, Rush Medical College
Neurology
Dr. Cynthia L. Comella, MD
|
|
Give Review
Cynthia L. Comella, MD is an expert in the field of Neurology. She researched medicine at University of Cincinnati College of Medicine. She has 3 awards "Chicago Magazine: Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Most Compassionate Doctor". Cynthia Comella is a published doctor. She has 101 publications published. The most current publication "Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease." Doctor Cynthia L. Comella, MD is registered with Medicare.
Publications
- Botulinum Toxin Treatment of Cervical Dystonia.
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
- Secured web-based video repository for multicenter studies.
- Primary results from the cervical Dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
- When brawn benefits brain: physical activity and Parkinson's Disease risk.
- Subthalamic nucleus--sensorimotor cortex functional connectivity in de novo and moderate Parkinson's Disease.
- An international survey of patients with cervical Dystonia.
- Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review.
- The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.
- Distinct functional and macrostructural brain changes in Parkinson's Disease and multiple system atrophy.
- Cervical Dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).
- Two-Year Exercise Program Improves Physical Function in Parkinson's Disease: The PRET-PD Randomized Clinical Trial.
- Beyond a motor disorder: A prospective evaluation of sleep quality in cervical Dystonia.
- Treatment of Restless Legs Syndrome.
- A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical Dystonia.
- Designing Clinical Trials for Dystonia.
- Cognitive and Motor Function in Long-Duration PARKIN-Associated Parkinson Disease.
- Diffusion, spread, and migration of botulinum toxin.
- The focal Dystonias: Current views and challenges for future research.
- Diffusion tensor imaging of Parkinson's Disease, atypical parkinsonism, and essential tremor.
- Force control deficits in individuals with Parkinson's Disease, multiple systems atrophy, and progressive supranuclear palsy.
- Reliability of a new scale for Essential tremor.
- Jaw-opening Dystonia: Quality of life after botulinum toxin injections.
- Basal ganglia hypoactivity during grip force in drug naïve Parkinson's Disease.
- Rationale for delayed-start study of pramipexole in Parkinson's Disease: the PROUD study.
- Treatment of insomnia in Parkinson's Disease: a controlled trial of eszopiclone and placebo.
- Predictors of parkin mutations in early-onset Parkinson Disease: the consortium on risk for early-onset Parkinson Disease study.
- Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson Disease.
- Stimulation-induced parkinsonism after posteroventral deep brain stimulation of the globus pallidus internus for craniocervical Dystonia.
- Changes in the relationship between movement velocity and movement distance in primary focal hand Dystonia.
- Sleep disorders in Parkinson's Disease.
- Parkinson's Disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.
- Parkinson's Disease--Part 2: Treatment of motor symptoms.
- Parkinson's Disease--Part 3: Neuropsychiatric symptoms.
- Sleep disorders in Parkinson's Disease: an overview.
- Restless legs syndrome in Parkinson's Disease and other neurodegenerative Diseases of the central nervous system.
- Strength deficits in primary focal hand Dystonia.
- Rating scale for psychogenic movement Disorders: scale development and clinimetric testing.
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical Dystonia: results of the first US randomized, double-blind, placebo-controlled study.
- Restless legs Syndrome.
- Nocturnal activity with nighttime pergolide in Parkinson Disease: a controlled study using actigraphy.
- Force control and Disease severity in Parkinson's Disease.
- Botulinum toxins in neurological Disease.
- Sleep disturbances in Parkinson's Disease.
- Treatment of Dystonia.
- Effect of medication on EMG patterns in individuals with Parkinson's Disease.
- Restless legs Syndrome: treatment with dopaminergic agents.
- Daytime sleepiness, agonist therapy, and driving in Parkinson Disease.
- Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
- Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia.
- A randomized, controlled trial of remacemide for motor fluctuations in Parkinson''s Disease.
- Partial deficiency of antidiuretic hormone in a cat.
- Assessment: Botulinum neurotoxin for the treatment of movement Disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee ...
- The relation between depression and parkin genotype: the CORE-PD study.
- Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.
- Pre-operative evaluations for DBS in Dystonia.
- Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial.
- Dystonias of the head and neck: An overview.
- Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE).
- Scales to assess sleep impairment in Parkinson's Disease: critique and recommendations.
- Frequency of known mutations in early-onset Parkinson Disease: implication for genetic counseling: the consortium on risk for early onset Parkinson Disease study.
- Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's Disease.
- Treatment of early Parkinson''s Disease. Part 2.
- Treatment of early Parkinson''s Disease. Part 1.
- Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign Essential blepharospasm: a randomized, placebo-controlled, phase II trial.
- Fatigue in Parkinson''s Disease: a review.
- Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations.
- Sleep episodes in Parkinson''s Disease: more questions remain.
- A teaching videotape for the assessment of Essential tremor.
- Use of botulinum toxin type A in the treatment of cervical Dystonia.
- Menstrual-related changes in motoric function in women with Parkinson's Disease.
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical Dystonia.
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical Dystonia.
- Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's Disease.
- Extensor truncal Dystonia: successful treatment with botulinum toxin injections.
- The effect of changes in head posture on the patterns of muscle activity in cervical Dystonia (CD).
- Sustained effect of high-dose intrathecal baclofen in primary generalized Dystonia: a 2-year follow-up study.
- Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.
- [Botulin toxin: principles of action and neurological indications].
- Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical Dystonia.
- Polysomnographic sleep measures in Parkinson's Disease patients with treatment-induced hallucinations.
- Physical therapy and Parkinson's Disease: a controlled clinical trial.
- Akathisia in Parkinson's Disease.
- The adrenal medullary transplant operation for Parkinson's Disease: clinical observations in five patients.
- Adrenal medullary transplant to the striatum of patients with advanced Parkinson's Disease: 1-year motor and psychomotor data.
- New approaches in the treatment of the Dystonias.
- Dysphagia after botulinum toxin injections for spasmodic Torticollis: clinical and radiologic findings.
- Botulinum toxin injection for spasmodic Torticollis: increased magnitude of benefit with electromyographic assistance.
- Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.
- Control of movement distance in Parkinson's Disease.
- Estrogen, progesterone, and tic severity in women with Gilles de la Tourette Syndrome.
- A randomized, double masked, controlled trial of botulinum toxin type A in Essential hand tremor.
- Rating scales for Dystonia: a multicenter assessment.
- Longitudinal outcome of Parkinson''s Disease patients with psychosis.
- Benefits and risks of pharmacological treatments for Essential tremor.
- Association of daytime napping and Parkinsonian signs in Alzheimer''s Disease.
- Sleep disturbances and excessive daytime sleepiness in Parkinson Disease: an overview.
- Can families be screened for cervical Dystonia using a telephone interview?
- Rate of force production and relaxation is impaired in patients with focal hand Dystonia.
- Clinimetric testing of the comprehensive cervical Dystonia rating scale.
Schools
University Of Cincinnati College Of Medicine
Rush Presby St Lukes
Procedures Preformed
- Non-Cosmetic Chemodenervation
Conditions Treated
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- Carpal Tunnel Syndrome
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Chicago Magazine: Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Most Compassionate Doctor
Education
-
Rush University Medical Center -
University of Cincinnati College of Medicine
Hospital
-
Rush University Medical Center
Drug Facts
| NPI NUMBER | 1588640940 | |
| NPPES Provider LastName | COMELLA | |
| NPPES Provider FirstName | CYNTHIA | |
| NPPES Provider ZIPCode | 606123841 | |
| NPPES Provider State | IL | |
| Specialty Description | Neurology | |
| Total Claim Count | 1326.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588640940 |
| Last Name Of The Provider | COMELLA |
| First Name Of The Provider | CYNTHIA |
| View All |
Similar Doctors
|
|
Dr. Charles N. Swisher, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Joya Paul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. Aiken, MD |
|
Dr. John J. Millichap, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aleksandra Stobnicki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roumen Balabanov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arun S. Chhabra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kapil Sachdeva, MD |
|
|
Goro Osawa |